Sector portfolio · VC firm · United States
Norwest Venture Partners' Biotech portfolio
Norwest Venture Partners has backed 22 Biotech startups in rounds we track, $2.4B between them, shown by the stage each has reached. The best-funded is Billiontoone.
Norwest Venture Partners's whole portfolioNorwest Venture Partners's profile
Funding by segment
- Series C and later$958M8
- Stage not reported$596M6
- Series A$398M4
- Series B$423M4
Where they are based
- United States21$2.3B
- Switzerland1$80M
United States
SwitzerlandFounded
4 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M5
- $50M to $250M14
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
18 of 22 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States21
- Switzerland1
Startups by country, 2 countries in all.
Segment by segment
Series C and later
8 startups · $958M raised
SetPoint MedicalSetPoint Medical is a commercial-stage medical technology company founded in 2007, focused on developing bioelectronic therapies fUnited States$256M
Elligo Health ResearchElligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies.United States$160M
CareCloudCareCloud, Inc., formerly MTBC, provides cloud-based technology-enabled software and services for medical practices in the US.United States$130M
TalkspaceTalkspace is a digital therapy company that offers online therapy, online counseling, psychiatry and medication management, and self-care.United States$109M
Nectero MedicalNectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.United States$96M
ClearDATAClearDATA is a cloud compliance and security solution designed specifically for the healthcare industry.United States$80M
MBX BiosciencesMBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.United States$64M
TelcareTelcare develops machine-2-machine cellular technology that wirelessly connects patients and physicians to cure chronic illnesses.United States$63M
Stage not reported
6 startups · $596M raised
BillionToOneBillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.United States$280M
Silk Road MedicalSilk Road Medical specializes in providing medical devices and solutions for the treatment of vascular diseases.United States$220M
Science ExchangeScience Exchange, the R&D Services Management company, empowers research organizations to accelerate science and drive innovation United States$54M
Onsite DentalOnsite Dental is a national dental care provider that offers high-quality, personalized oral health services directly at workplaceUnited States$20M
ApostropheDermatology crafted to you and delivered to your door.United States$16M
Excision BioTherapeuticsExcision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.United States$6.8M
Series A
4 startups · $398M raised
Callio TherapeuticsCallio Therapeutics is a biotechnology company founded in 2025, focused on developing next-generation dual-payload antibody-drug cUnited States$187M
Ouro MedicinesOuro Medicines is a biotechnology company based in South San Francisco, established in 2025 by Monograph Capital in partnership with GSK.United States$120M- MTMosanna TherapeuticsSwitzerland$80M
- RVRitual VitaminsUnited States$11M
Series B
4 startups · $423M raised
Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$220M
Nuvig TherapeuticsNuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune.United States$161M
NanopathNanopath Inc.United States$25M- NNextHealthUnited States$17M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Norwest Venture Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Norwest Venture Partners?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.